Comment from Walgreens
-
Subject: Docket No. FDA–2013-D–1444: Pharmacy Compounding of Human Drug Products Under Section 503A of the FDCA Walgreen Co. (“Walgreens”) is pleased to submit comments to the...
-
Public Submission
-
Posted:02/06/2014
-
ID:FDA-2013-D-1444-0025
No comments:
Post a Comment